First Trust Advisors LP Corcept Therapeutics Inc Transaction History
First Trust Advisors LP
- $118 Billion
- Q2 2025
A detailed history of First Trust Advisors LP transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, First Trust Advisors LP holds 537,186 shares of CORT stock, worth $39.5 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
537,186
Previous 924,317
41.88%
Holding current value
$39.5 Million
Previous $106 Million
62.65%
% of portfolio
0.03%
Previous 0.1%
Shares
32 transactions
Others Institutions Holding CORT
# of Institutions
466Shares Held
82.7MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.22 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$712 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$568 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$461 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$285 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.88B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...